ACAshley Mae Conard

Ashley Mae Conard

*This is an algorithmically generated author record based on publicly available information.

Ashley Mae Conard has a total of 65 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • The Evidence Aggregator: AI reasoning applied to rare disease diagnostics

    by Hope Twede, Lynn Pais, Samantha Bryen, Emily O’HEir, Greg Smith, Ron Paulsen, Christina A. Austin-Tse, Alex Bloemendal, Cas Simons, Amanda K. Hall, et al.

  • Open Access

    A biologically annotated neural network for proteomic discovery in Parkinson’s disease

    by Avish Vijayaraghavan, Lorin Crawford, Krishnakant Saboo, Ava P. Amini, Ashley Mae Conard, Abby L. Olsen, Lana M. Chahine, Kristen A. Severson

    A bstract: Machine learning models that can utilize high-dimensional data to make predictions and derive biological insights can improve understanding of diseases. Here, we develop a biologically annotated neural network model for proteomics data (P-BANN) which has several practical advantages: (1) it incorporates known relationships between proteins and signaling pathways into its architecture design; (2) it uses Bayesian principles to enable variable selection on the most important proteins for a disease of interests; and (3) it combines structured and black-box variational inference to analyze different classes of phenotypes at scale. To demonstrate the value of the approach, we apply P-BANN to one of the most common neurodegenerative disorders: Parkinson’s disease (PD). We consider two biomarker-defined phenotypes within the PD population: presence of neuronal-predominate aggregated α -synuclein in cerebrospinal fluid, and changes in dopamine transporter binding in the striatum on imaging. By considering biomarkers of both neuropathological hallmarks of PD, we can examine the extent to which their underlying biology is connected. Using the P-BANN framework, we discover sparse, statistically-calibrated sets of proteins which map to pathways, enabling more straightforward interpretation and generation of testable hypotheses.

  • Open Access

    AI-Enhanced Sensemaking: Exploring the Design of a Generative AI-Based Assistant to Support Genetic Professionals

    by Angela Mastrianni, Hope Twede, Aleksandra Sarcevic, Jeremiah Wander, Christina Austin-Tse, Scott Saponas, Heidi Rehm, Ashley Mae Conard, Amanda K. Hall

    Generative AI has the potential to transform knowledge work, but further research is needed to understand how knowledge workers envision using and interacting with generative AI. We investigate the development of generative AI tools to support domain experts in knowledge work, examining task delegation and the design of human–AI interactions. Our research focused on designing a generative AI assistant to aid genetic professionals in analyzing whole genome sequences (WGS) and other clinical data for rare disease diagnosis. Through interviews with 17 genetics professionals, we identified current challenges in WGS analysis. We then conducted co-design sessions with six genetics professionals to determine tasks that could be supported by an AI assistant and considerations for designing interactions with the AI assistant. From our findings, we identified sensemaking as both a current challenge in WGS analysis and a process that could be supported by AI. We contribute an understanding of how domain experts envision interacting with generative AI in their knowledge work, a detailed empirical study of WGS analysis, and three design considerations for using generative AI to support domain experts in sensemaking during knowledge work.


  • Open Access

    The Evidence Aggregator: AI reasoning applied to rare disease diagnostics

    by Hope Twede, Lynn Pais, Samantha Bryen, Emily O’HEir, Greg Smith, Ron Paulsen, Christina A. Austin-Tse, Alex Bloemendal, Cas Simons, Amanda K. Hall, et al.

    Variant assessment of rare disease diagnostics depends on using domain knowledge in the time- consuming process of retrieving, reviewing, and synthesizing clinical and technical information. To address these challenges, we developed the Evidence Aggregator (EvAgg), an open-source, generative-AI-based tool designed for rare disease diagnosis that systematically extracts relevant information from the scientific literature for any human gene. EvAgg provides a thorough and current summary of observed genetic variants and their associated clinical features, enabling rapid synthesis of evidence concerning gene-disease relationships. We constructed an expert-curated dataset and evaluated EvAgg’s performance. EvAgg achieves 92% recall in identifying relevant papers, 96% recall in detecting instances of genetic variation within those papers, and ∼80% accuracy in extracting individual case and variant-level content (e.g. zygosity, inheritance, variant type, and phenotype). Further, EvAgg complemented the process of manual literature review by identifying substantial additional relevant information. When tested with analysts in rare disease case analysis, EvAgg reduced review time by 34% (p-value < 0.002) and increased the number of papers, variants, and cases evaluated per unit time. These savings have the potential to reduce diagnostic latency and increase solve rates for challenging rare disease cases.


  • Open Access

    AI-Enhanced Sensemaking: Exploring the Design of a Generative AI-Based Assistant to Support Genetic Professionals

    by Angela Mastrianni, Hope Twede, Aleksandra Sarcevic, Jeremiah Wander, Christina Austin-Tse, Scott Saponas, Heidi Rehm, Ashley Mae Conard, Amanda K. Hall

    Generative AI has the potential to transform knowledge work, but further research is needed to understand how knowledge workers envision using and interacting with generative AI. We investigate the development of generative AI tools to support domain experts in knowledge work, examining task delegation and the design of human-AI interactions. Our research focused on designing a generative AI assistant to aid genetic professionals in analyzing whole genome sequences (WGS) and other clinical data for rare disease diagnosis. Through interviews with 17 genetics professionals, we identified current challenges in WGS analysis. We then conducted co-design sessions with six genetics professionals to determine tasks that could be supported by an AI assistant and considerations for designing interactions with the AI assistant. From our findings, we identified sensemaking as both a current challenge in WGS analysis and a process that could be supported by AI. We contribute an understanding of how domain experts envision interacting with generative AI in their knowledge work, a detailed empirical study of WGS analysis, and three design considerations for using generative AI to support domain experts in sensemaking during knowledge work. CCS CONCEPTS: Human-centered computing, Human-computer interaction, Empirical studies in HCI Additional Keywords and Phrases: whole genome sequencing, generative AI, large language models, knowledge work, sensemaking, co-design, rare disease Contact Author: Angela Mastrianni (This work was done during the author's internship at Microsoft Research) Ashley Mae Conard and Amanda K. Hall contributed equally

  • Open Access

    Multioviz: an interactive platform for in silico perturbation and interrogation of gene regulatory networks

    by Helen Xie, Lorin Crawford, Ashley Mae Conard

    In this paper, we aim to build a platform that will help bridge the gap between high-dimensional computation and wet-lab experimentation by allowing users to interrogate genomic signatures at multiple molecular levels and identify best next actionable steps for downstream decision making. We introduce : a publicly accessible package and web application platform to easily perform in silico hypothesis testing of generated gene regulatory networks. We demonstrate the utility of by conducting an end-to-end analysis in a statistical genetics application focused on measuring the effect of in silico perturbations of complex trait architecture. By using a real dataset from the Wellcome Trust Centre for Human Genetics, we both recapitulate previous findings and propose hypotheses about the genes involved in the percentage of immune CD8+ cells found in heterogeneous stocks of mice. Source code for the package is available at https://github.com/lcrawlab/multio-viz and an interactive version of the platform is available at https://multioviz.ccv.brown.edu/.


  • Open Access

    Multioviz: an interactive platform for in silico perturbation and interrogation of gene regulatory networks

    by Helen Xie, Lorin Crawford, Ashley Mae Conard

    In this paper, we aim to build a tool that will help bridge the gap between high-dimensional computation and wet-lab experimentation by allowing users to interrogate genomic signatures at multiple molecular levels and identify best next actionable steps for downstream decision making. We introduce Multioviz : a publicly accessible R package and web application platform to easily perform in silico hypothesis testing of generated gene regulatory networks. We demonstrate the utility of Multioviz by conducting an end-to-end analysis in a statistical genetics application focused on measuring the effect of in silico perturbations of complex trait architecture. By using a real data set from the Wellcome Trust Centre for Human Genetics, we both recapitulate previous findings and propose hypotheses about the genes involved in the percentage of immune CD8+ cells found in heterogeneous stocks of mice. Source code for the Multioviz R package is available at https://github.com/lcrawlab/multio-viz and an interactive version of the platform is available at multioviz.ccv.brown.edu .

  • Open Access

    Sex‐specific aging in animals: Perspective and future directions

    by Anne M. Bronikowski, Richard P. Meisel, Peggy R. Biga, James R. Walters, Judith E. Mank, Erica Larschan, Gerald S. Wilkinson, Nicole Valenzuela, Ashley Mae Conard, João Pedro de Magalhães, et al.

    Sex differences in aging occur in many animal species, and they include sex differences in lifespan, in the onset and progression of age‐associated decline, and in physiological and molecular markers of aging. Sex differences in aging vary greatly across the animal kingdom. For example, there are species with longer‐lived females, species where males live longer, and species lacking sex differences in lifespan. The underlying causes of sex differences in aging remain mostly unknown. Currently, we do not understand the molecular drivers of sex differences in aging, or whether they are related to the accepted hallmarks or pillars of aging or linked to other well‐characterized processes. In particular, understanding the role of sex‐determination mechanisms and sex differences in aging is relatively understudied. Here, we take a comparative, interdisciplinary approach to explore various hypotheses about how sex differences in aging arise. We discuss genomic, morphological, and environmental differences between the sexes and how these relate to sex differences in aging. Finally, we present some suggestions for future research in this area and provide recommendations for promising experimental designs.


  • Open Access

    TIMEOR: a web-based tool to uncover temporal regulatory mechanisms from multi-omics data

    by Ashley Mae Conard, Nathaniel Goodman, Yanhui Hu, Norbert Perrimon, Ritambhara Singh, Charles Lawrence, Erica Larschan

    Uncovering how transcription factors regulate their targets at DNA, RNA and protein levels over time is critical to define gene regulatory networks (GRNs) and assign mechanisms in normal and diseased states. RNA-seq is a standard method measuring gene regulation using an established set of analysis stages. However, none of the currently available pipeline methods for interpreting ordered genomic data (in time or space) use time-series models to assign cause and effect relationships within GRNs, are adaptive to diverse experimental designs, or enable user interpretation through a web-based platform. Furthermore, methods integrating ordered RNA-seq data with protein–DNA binding data to distinguish direct from indirect interactions are urgently needed. We present TIMEOR (Trajectory Inference and Mechanism Exploration with Omics data in R), the first web-based and adaptive time-series multi-omics pipeline method which infers the relationship between gene regulatory events across time. TIMEOR addresses the critical need for methods to determine causal regulatory mechanism networks by leveraging time-series RNA-seq, motif analysis, protein–DNA binding data, and protein-protein interaction networks. TIMEOR’s user-catered approach helps non-coders generate new hypotheses and validate known mechanisms. We used TIMEOR to identify a novel link between insulin stimulation and the circadian rhythm cycle. TIMEOR is available at https://github.com/ashleymaeconard/TIMEOR.git and http://timeor.brown.edu.


  • Open Access

    Sex-specific transcript diversity is regulated by a maternal transcription factor in early Drosophila embryos

    by Mukulika Ray, Ashley Mae Conard, Jennifer Urban, Joseph Aguilera, Annie Huang, Pranav Mahableshwarkar, Smriti Vaidyanathan, Erica Larschan

    Co-transcriptional splicing coordinates the processes of transcription and splicing and is driven by transcription factors (TFs) and diverse RNA-binding proteins (RBPs). Yet the mechanisms by which specific TFs and RBPs function together in context-specific ways to drive precise co-transcriptional splicing at each of thousands of genomic loci remains unknown. Therefore, we have used sex-specific splicing in Drosophila as a model to understand how the function of TFs and RBPs is coordinated to transcribe and process specific RNA transcripts at the correct genomic locations. We show widespread sex-specific transcript diversity occurs much earlier than previously thought and present a new pipeline called time2splice to quantify splicing changes over time. We define several mechanisms by which the essential and functionally-conserved CLAMP TF functions with specific RBPs to precisely regulate co-transcriptional splicing: 1) CLAMP links the DNA of gene bodies of sex-specifically spliced genes directly to the RNA of target genes and physically interacts with snRNA and protein components of the splicing machinery; 2) In males, CLAMP regulates the distribution of the highly conserved RBP M ale le ss (MLE) (RNA Helicase A) to prevent aberrant sex-specific splicing; 3) In females, CLAMP modulates alternative splicing by directly binding to target DNA and RNA and indirectly through regulating the splicing of sex lethal , the master regulator of sex determination. Overall, we provide new insight into how TFs function specifically with RBPs to drive alternative splicing.